2021-11-16-世界卫生组织-Cervical_cancer_New_Zealand_2021_country_profile_1页_64kb

Summary of New Zealand Cervical Cancer Profile

Morbidity and Mortality

• Crude cervical cancer incidence: 7.1 per 100,000 women (2020).
• Age-standardized incidence rate: 5.6 per 100,000 women (2020).
• Cumulative risk of cervical cancer by age 74: 0.5%.
• Cervical cancer deaths: 16,400 females (2019).
• Mortality-to-incidence ratio: 0.47 (2020).
• Population-based cancer registry exists.

Primary Prevention (HPV Vaccination)

• HPV vaccination programme coverage among girls by age 15: 70% (2020).
• HPV included in national vaccination programme since 2009.
• Primary target cohort: Girls aged 9-14 years.
• Scale: Final dose coverage by age 15 and ongoing doses.
• Year of introduction: 2009.
• Related risk factors addressed: Tobacco use prevalence (women aged 15+, 0.5% in 2020).

Secondary Prevention (Screening)

• National screening programme for cervical cancer exists.
• Primary screening test used: Cytology.
• Target age range: 25-69 years.
• Ever screened: 97% of women.
• Percentage screened in last 5 years: 87% among women aged 25-69.
• Programme and guidelines exist for early detection at primary care level, referral systems from primary to secondary/tertiary care.

Treatment and Supportive Care

• National guidelines on cervical cancer management exist.
  Radiography and brachytherapy units: Not specified or data not available in summary.
• Radiation oncologists, surgeons, and other medical staff available based on reported numbers (e.g., radiation oncologists per 2019 data).
• Pathology and imaging services participate.
• Palliative care generally available in the public health system.

WHO Cervical Cancer Elimination Strategy Targets (2030)

• Aligns with global goals for reducing incidence and deaths, with country-specific efforts in prevention and screening.